Yesterday we had Thanksgiving here in the snowy North. Many families and friends got together to break bread, play catch up and tell stories. It wouldn't surprise me if a number of conversations about RVX took place. Here is this biotech company that is less than 3 months away from completing dosing of a phase 3 trial, about 5 to 6 months away from Top Line results coming out and "maybe" up to 9 or 10 months away from full trial results. I can just hear the conversations, so far there have been no safety issues and 6 DSMB reports that say so. The company seems to be doing everything possible to have the best possible outcome. Not having an SSRA could give them a 1% to 2% increase in the desired outcome. The potential annual sales of this drug, if it passes the pre stated goal plus shows good or great numbers on the secondary outcomes could be astronomical. 

There sure isn't much time left before all this info is available to the world. There is not much stock available for sale either. Anyone who now wants a position is probably going to have to pay up a little which looks like what has happened today. Good food, good friends, a stock that's up over 100% in the last few months and a short time to the end of the rainbow.

Sounds like a good story to me.

tada